Skip to main content
. Author manuscript; available in PMC: 2016 May 12.
Published in final edited form as: FASEB J. 2007 Jan 11;21(4):1145–1152. doi: 10.1096/fj.06-7439com

TABLE 1.

Binding constants for albumin: RAGE interaction

Kd
(µg/ml)
Bmax
(ng/well)
IC50
(µg/ml)
Alb n.d. n.d. n.d.
HOCl-Alb (25:1) 15.7 ± 1.2 10.5 ± 0.9 n.d.
HOCl-Alb (50:1) 14.6 ± 0.3 20.3 ± 1.6 29.0 ± 5.1
HOCl-Alb (100:1) 10.6 ± 0.6 42.8 ± 5.2 14.4 ± 3.5
MPO-Alb 16.1 ± 1.1 24.6 ± 1.7 20.1 ± 3.8
AGE-Alb 46.9 ± 4.6 52.6 ± 4.2 51.9 ± 15.2

Kd and Bmax values for 125I-soluble receptor for advanced glycation end products (RAGE) binding to microtiter wells coated with the indicated albumin preparations are listed. IC50 values for 125I-sRAGE binding inhibition to AGE-albumin (AGE-Alb)-coated microtiter wells by albumin (Alb), HOCl-Alb (at indicated oxidant:protein molar ratio), MPO-Alb (calculated HOCl:protein molar ratio of 50:1), and AGE-Alb are given. Calculations were performed by nonlinear regression analysis (GraphPad Prism). n.d. = non determined.